What Are Lesions on the Liver? Types and What They Mean

A liver lesion is any abnormal area of tissue in the liver, and the term covers everything from a harmless fluid-filled cyst to a cancerous tumor. Most liver lesions are benign. In a large ultrasound study of more than 45,000 patients, about 15% had at least one focal liver lesion, and the vast majority turned out to be noncancerous findings like fatty sparing, simple cysts, or hemangiomas.¹ Still, the word “lesion” on an imaging report can be alarming, and understanding the spectrum of possibilities helps put it in context.

Why Liver Lesions Are Found So Often

The rise in liver lesion detection has less to do with a rise in liver disease and more to do with better imaging technology. Ultrasound, CT, and MRI are used routinely now for all kinds of complaints, and the liver is a large organ that sits right in the field of view for many abdominal scans. Benign liver tumors are commonly detected as incidental findings during these imaging studies.² In other words, a scan ordered for kidney stones or gallbladder pain might reveal a liver lesion that was never causing symptoms. These incidental findings are sometimes called “incidentalomas,” and they can become a source of anxiety even though they usually turn out to be benign.³

The Most Common Benign Lesions

The benign category is broad, but a few types account for the overwhelming majority of findings.

Hemangiomas

Hepatic hemangiomas are the single most common benign liver tumor. They are tangles of blood vessels, essentially a vascular malformation rather than a true growth in the usual sense. Most are small, cause no symptoms, and are discovered by accident on imaging. Fewer than 40% show any progression over time.⁴ There has been speculation that hormones, particularly estrogen, might influence their growth, but the evidence is not strong enough to warrant avoiding hormonal medications in people who have them.⁴ Unless a hemangioma grows very large and causes pressure symptoms, it is typically left alone.

Focal Nodular Hyperplasia

Focal nodular hyperplasia (FNH) is the second most common solid benign liver lesion. It is not truly a tumor but rather an overgrowth of normal liver cells thought to develop in response to a localized blood vessel abnormality. Recent research points to changes in genes that regulate blood vessel formation as the underlying driver.⁵ FNH is more common in women of reproductive age and often shows a characteristic central scar on imaging that helps distinguish it from other masses. It has virtually no risk of turning malignant, so it rarely needs treatment.

Hepatic Adenomas

Hepatic adenomas are less common than hemangiomas or FNH, but they matter more clinically because some subtypes carry a risk of bleeding or becoming cancerous. Adenomas are now classified into six molecular subtypes, and the subtype determines how dangerous the lesion is.⁶ One subtype with a specific gene mutation has a malignant transformation rate as high as 40%, while another carries a very high risk of symptomatic hemorrhage.⁷ Because of these risks, surgical removal is generally recommended for adenomas in men, adenomas larger than about 5 cm, or adenomas with a high-risk molecular profile.⁸ Oral contraceptive use is a well-known risk factor, and stopping the pill sometimes causes smaller adenomas to shrink.

Cysts and Fluid-Filled Lesions

Simple liver cysts are extremely common. In the ultrasound study mentioned earlier, cysts were found in nearly 6% of patients.¹ They are thin-walled sacs filled with fluid, can range from under a centimeter to 30 cm across, and almost never cause trouble.⁹ Most people with a simple cyst will never know it is there unless an imaging study happens to pick it up.

When cysts become clinically relevant is when there are many of them. Polycystic liver disease is a genetic condition in which the liver develops numerous cysts, often alongside polycystic kidney disease. In advanced cases the liver becomes significantly enlarged. Patients with severely symptomatic polycystic liver disease report abdominal pain, and some develop complications like jaundice or fluid buildup.¹⁰ Complex cysts with multiple internal divisions or irregular walls require closer investigation, because a small minority turn out to be cystic tumors rather than simple cysts.

Liver Abscesses

A liver abscess is a pocket of infection inside the liver, and it represents a very different kind of lesion from tumors or cysts. The two main types are amoebic abscesses, caused by the parasite Entamoeba histolytica, and pyogenic abscesses, caused by bacteria. In many parts of the world the amoebic type is more common, while in industrialized countries bacterial abscesses predominate. One study from India found that about 62% of liver abscesses were amoebic and 25% were pyogenic.¹¹ By contrast, a cohort from a high-income setting found that more than 93% of abscesses were pyogenic.¹²

The two types tend to look different clinically. Amoebic abscesses are more likely to appear as a single large collection in the right lobe, often in younger men with a history of travel to areas where the parasite is common. Pyogenic abscesses tend to occur in older patients and are more often multiple; diabetes and biliary tract disease are common risk factors.¹³ Both types cause fever, abdominal pain, and feeling generally unwell, and both require treatment with antibiotics or antiparasitic drugs. Drainage may be necessary for larger abscesses.

Malignant Liver Lesions

When people hear “liver lesion,” cancer is often what they fear. Malignant liver lesions fall into two broad categories: cancers that start in the liver itself and cancers that have spread from elsewhere.

Primary Liver Cancers

Hepatocellular carcinoma (HCC) is by far the most common primary liver cancer. It almost always develops against a background of chronic liver disease, particularly cirrhosis from viral hepatitis, alcohol use, or fatty liver disease. Non-alcoholic fatty liver disease is a rapidly growing cause of HCC in many developed countries, and it poses a particular surveillance challenge because a meaningful proportion of these cancers arise even before the liver has become cirrhotic.¹⁴ Patients with fatty liver disease who develop HCC also tend to be older and have more accompanying health conditions, which complicates treatment options.

Cholangiocarcinoma, or bile duct cancer, is the other major primary liver malignancy. It arises from the cells lining the bile ducts and can occur inside the liver or in the ducts outside it. It is an aggressive cancer with a very poor prognosis. The strongest risk factors include bile duct cysts, bile duct stones, cirrhosis, and hepatitis B and C infection.¹⁵ Parasitic liver fluke infections are a leading cause in parts of Southeast Asia. Other risk factors include diabetes, obesity, and primary sclerosing cholangitis, a chronic inflammatory condition of the bile ducts.¹⁶

Metastatic Lesions

Because the liver filters blood from the entire digestive tract, it is one of the most common sites where cancers from other organs end up. In fact, metastatic liver lesions are far more common than primary liver cancers in many populations. Colorectal cancer is the classic example, but cancers of the breast, lung, pancreas, and stomach also frequently spread to the liver. Metastases usually appear as multiple lesions scattered throughout the liver, which is an important clue that distinguishes them from most primary tumors. Treatment for liver metastases depends entirely on the original cancer and its stage.

Pseudolesions That Mimic Real Ones

Not everything that looks like a lesion on imaging actually is one. Focal fatty sparing is a perfect example. When the liver accumulates fat (a very common finding), it does not always do so uniformly. Small patches of normal liver tissue surrounded by fatty tissue can look like distinct nodules on ultrasound, sometimes mimicking metastatic tumors closely enough to cause alarm.¹⁷ In the large ultrasound study referenced earlier, focal fatty sparing was actually the single most commonly recorded “lesion,” appearing in about 6% of patients.¹

The distribution patterns of fatty deposition can be quite varied and create diagnostic confusion, especially on ultrasound alone.¹⁸ One helpful clue is that these pseudolesions tend to change or disappear on follow-up imaging as the liver’s fat content fluctuates. If a finding vanishes on a repeat scan, it was almost certainly fatty sparing rather than a true tumor.¹⁹ MRI is particularly good at sorting these out, because it can directly measure fat content in tissue.

How Doctors Figure Out What a Lesion Is

When a lesion is discovered, the radiologist’s first job is figuring out whether it needs further investigation. Many can be confidently diagnosed on the initial imaging study alone, particularly simple cysts and typical hemangiomas, which have recognizable appearances on ultrasound or CT. When the diagnosis is uncertain, the lesion gets a more detailed look, often with contrast-enhanced CT or MRI.

The way a lesion behaves after contrast dye is injected provides crucial information. Doctors pay close attention to how the lesion takes up dye during the arterial phase (when blood first rushes through) and whether it “washes out” in later phases. Malignant lesions, especially HCC, tend to light up brightly in the arterial phase and then wash out quickly, a pattern that is highly characteristic.²⁰ However, this pattern is not exclusive to HCC. Other lesions including FNH, some adenomas, and even certain metastases can show similar enhancement, which means the radiologist must consider the full picture rather than relying on a single imaging feature.²¹

For people at high risk for liver cancer, a standardized system called LI-RADS (Liver Imaging Reporting and Data System) helps radiologists categorize findings on a scale from definitely benign to definitely HCC. The system standardizes the language and criteria used in imaging reports, reducing the ambiguity that used to make communication between radiologists and clinicians inconsistent.²²

Blood tests play a supporting role. Alpha-fetoprotein (AFP) is the best-known blood marker for liver cancer, but on its own it catches only about 63% of hepatocellular carcinomas.²³ Combining AFP with other markers improves accuracy, but no blood test alone is reliable enough to confirm or rule out cancer. They work best as screening tools in people already known to be at elevated risk.

When imaging and blood tests are not definitive, a biopsy may be necessary. Despite all the advances in non-invasive testing, liver biopsy remains the most reliable way to diagnose uncertain liver nodules.²⁴ Combining two sampling techniques during biopsy (fine needle aspiration and core needle biopsy together) improves sensitivity for detecting malignancy to about 98%, compared with roughly 87% or 92% when either technique is used alone.²⁵

When Treatment Is and Is Not Needed

The single most important thing to understand about liver lesions is that the majority require nothing more than confirmation that they are benign. A typical hemangioma, a simple cyst, or an FNH does not need surgery, medication, or ongoing monitoring in most cases. The main job of the diagnostic workup is to make sure nothing dangerous is being missed, and once that reassurance is achieved, these lesions can safely be left alone.

Hepatic adenomas are the notable exception among benign lesions, as discussed above. And for malignant lesions, the treatment approach depends heavily on the type, number, size, and stage. Surgical resection remains the gold standard for HCC in patients whose liver function can tolerate it. For tumors that cannot be surgically removed, alternatives like arterial embolization combined with ablation have shown comparable overall survival rates in some studies, although recurrence-free survival tends to be shorter compared with surgery.²⁶

For people with fatty liver disease and cirrhosis, guidelines recommend regular screening for HCC, typically with ultrasound every six months. When ultrasound quality is poor, as it can be in patients with obesity, CT or MRI may be substituted.²⁷ People with fatty liver disease but no advanced scarring are generally not recommended for routine cancer screening, though the evidence on this group is still evolving.

Liver Lesions in Children

The landscape of liver lesions looks quite different in children compared with adults. While most focal liver lesions in adults are benign and discovered incidentally, the most common primary benign liver tumors in children are infantile hemangiomas and mesenchymal hamartomas. Malignant liver tumors in children are dominated by hepatoblastoma, a cancer that occurs mostly in children under age three, and hepatocellular carcinoma, which is much rarer in pediatric patients than in adults.²⁸ The diagnostic approach in children therefore follows a different pathway, with age and clinical context playing an even larger role in narrowing down what a lesion might be.

How Artificial Intelligence Is Changing Lesion Diagnosis

Interpreting liver imaging is one of the areas where AI tools are making real headway. Deep learning models trained on CT and MRI scans are now able to classify liver lesions as benign or malignant with accuracy above 94% in test settings, and can further sort malignant lesions into subtypes with accuracy approaching 89%.²⁹ These tools are not replacing radiologists, but they are proving useful as assistive technology. In one study, junior radiologists using an AI model improved their diagnostic accuracy by about 5 percentage points and read scans faster while also feeling more confident in their interpretations.³⁰ More broadly, AI-driven approaches are reducing the variability in readings between different radiologists, which has historically been one of the weak points of liver imaging.³¹ The technology is still in its early clinical stages, but the trajectory suggests it will become a standard part of the diagnostic toolkit within the next several years.